Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

The government agency says X no longer suits its communication needs.

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...

The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...